Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Navidea Signs Binding Framework For Commercialization Partnership With Jubilant Radiopharma

Aug 10 (Reuters) - Jubilant Life Sciences Ltd  JULS.NS :
    * NAVIDEA BIOPHARMACEUTICALS SIGNS BINDING FRAMEWORK FOR
COMMERCIALIZATION PARTNERSHIP WITH JUBILANT RADIOPHARMA
    * NAVIDEA BIOPHARMACEUTICALS INC - JUBILANT TO PROVIDE CO
WITH $19
MILLION IN FORM OF STOCK PURCHASES AND LICENSE FEES
    * NAVIDEA BIOPHARMACEUTICALS - IN CONNECTION WITH MOU,
JUBILANT
MADE A $1 MILLION EQUITY INVESTMENT IN CO IN EXCHANGE FOR A
LIMITED EXCLUSIVITY PERIOD

Source text for Eikon:  ID:nBw8G19fha 
Further company coverage:  JULS.NS 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))

Recent news on Jubilant Pharmova

See all news